Leuprolide or Goserelin Plus Thalidomide Compared With Leuprolide or Goserelin Alone in Treating Patients With Nonmetastatic Prostate Cancer

This study is ongoing, but not recruiting participants.

Study NCT00020085 Information provided by National Cancer Institute (NCI)

First Received: July 11, 2001 Last Updated: April 11, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Prostate Cancer

Additional conditions recognized in this trial

Prostatic Neoplasms

More general conditions related to this trial

Interventions listed in this trial

goserelin
leuprolide acetate
thalidomide

Additional drug interventions recognized in this trial

Leuprolide

More general drug interventions related to this trial

Sponsors listed in this trial